妊娠期接种新冠疫苗后胎儿与新生儿结局观察性研究的设计与分析指导
本文针对妊娠期接种新冠疫苗后胎儿与新生儿结局的观察性流行病学研究,讨论关键的研究设计、数据收集与分析问题,并提出简要指导以优化研究质量,使其最大程度服务于公共卫生决策。
要点
- 观察性流行病学研究是大规模评估妊娠期新冠疫苗安全性的重要补充手段。
- 妊娠期接种的观察性评估面临独特方法学挑战,新冠研究可能更为突出。
- 研究设计需统筹考虑孕妇自身及胎儿/新生儿的风险与获益。
核心结论
- 观察性流行病学研究是评估妊娠期新冠疫苗安全性的重要证据来源,需通过优化设计与分析保证质量以服务公共卫生决策。
研究设计与样本
- 本文为方法学指导类文章,讨论妊娠期接种新冠疫苗后胎儿与新生儿结局观察性研究的设计、数据收集与分析问题,未报告具体样本量。
主要发现
- 妊娠期接种的观察性评估存在若干独特方法学挑战,其中部分在新冠研究中可能更为明显。
临床怎么用
- 开展此类研究时应重视研究设计、数据收集与分析的關鍵方法学问题,以提升证据对公共卫生决策的价值。
局限性
- 本文为方法学讨论与简要指导,未报告具体研究数据或定量结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 vaccines are now being deployed as essential tools in the public health response to the global SARS-CoV-2 pandemic. Pregnant individuals are a unique subgroup of the population with distinctive considerations regarding risk and benefit that extend beyond themselves to their fetus/newborn. As a complement to traditional pharmacovigilance and clinical studies, evidence to comprehensively assess COVID-19 vaccine safety in pregnancy will need to be generated through observational epidemiologic studies in large populations. However, there are several unique methodological challenges that face observational assessments of vaccination during pregnancy, some of which may be more pronounced for COVID-19 studies. In this contribution, we discuss the most critical study design, data collection, and analytical issues likely to arise. We offer brief guidance to optimize the quality of such studies to ensure their maximum value for informing public health decision-making.
引用
- Fell DB, Dimitris MC, Hutcheon JA, et al. Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy. Vaccine. 2021. PMID: 33715900. doi:10.1016/j.vaccine.2021.02.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。